Skip to main content
Clinical Trials/NCT00575445
NCT00575445
Terminated
Not Applicable

The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients

Akron Children's Hospital1 site in 1 country100 target enrollmentNovember 2007
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Akron Children's Hospital
Enrollment
100
Locations
1
Primary Endpoint
Exhaled nitric oxide level
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
March 2015
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of asthma by pediatric pulmonologist
  • Age 6-18 years

Exclusion Criteria

  • Age \<6 years or \>18 years
  • history of bronchopulmonary dysplasia
  • history of cystic fibrosis
  • history of primary ciliary dyskinesia
  • current acute asthma exacerbation
  • current acute viral upper respiratory infection
  • recent ingestion of nitrate-rich foods

Outcomes

Primary Outcomes

Exhaled nitric oxide level

Time Frame: One office visit

Study Sites (1)

Loading locations...

Similar Trials